Direct Epidemio-Statistics — Expert office in epidemiostatistics and risk

We help our clients break free from statistical details in epidemiology and risk, so they can focus on what matters most: serving their clients and growing their business.

#news
Nov 2023 (2)Nov 2023Dec 2023 (0)Dec 2023Jan 2024 (0)Jan 2024Feb 2024 (0)Feb 2024Mar 2024 (0)Mar 2024Apr 2024 (0)Apr 2024May 2024 (0)May 2024Jun 2024 (0)Jun 2024Jul 2024 (0)Jul 2024Aug 2024 (0)Aug 2024Sep 2024 (0)Sep 2024Oct 2024 (2)Oct 2024Nov 2024 (3)Nov 2024Dec 2024 (0)Dec 2024Jan 2025 (1)Jan 2025Feb 2025 (1)Feb 2025Mar 2025 (0)Mar 2025Apr 2025 (1)Apr 2025May 2025 (0)May 2025Jun 2025 (1)Jun 2025Jul 2025 (0)Jul 2025Aug 2025 (0)Aug 2025Sep 2025 (1)Sep 2025Oct 2025 (0)Oct 2025Nov 2025 (7)Nov 2025Dec 2025 (0)Dec 2025Jan 2026 (3)Jan 2026Feb 2026 (0)Feb 2026Mar 2026 (4)Mar 2026Apr 2026 (1)Apr 2026May 2026 (1)May 2026Jun 2026 (3)Jun 2026
Upcoming
Scroll → for the next events
SITL 2026, Paris, FR
31 March – 2 April 2026
SITL 2026, Paris, FR
UK Rail 2026 (Railtex), Birmingham, UK
13–14 May 2026
UK Rail 2026 (Railtex), Birmingham, UK
Drive to Zero 2026, Paris, FR
2–3 June 2026
Drive to Zero 2026, Paris, FR
European Mobility Expo 2026 (EuMo), Paris, FR
9–11 June 2026
European Mobility Expo 2026 (EuMo), Paris, FR
Eurosatory 2026, Paris, FR
15–19 June 2026
Eurosatory 2026, Paris, FR

Our expertise

What are Direct Epidemio-Statistics' areas of expertise?

Statistical epidemiology

A broad, comprehensive spectrum of statistical methods to:
  • characterize, model, and compare your study populations
  • improve survival, quality of life, or complication counts
  • reduce the number of serious adverse events (SAEs)
  • conduct health surveillance.
Excerpts

Quantitative risk

Methods and solutions at every stage of your at-risk case management process, notably to:
  • better understand the pathogenesis of your adverse events
  • summarize and compare characteristics of studied populations
  • improve yields or techno-economic efficiency
  • proactively monitor your at-risk cases...
Excerpts

Market access marketing

Argumentation intelligence and techno-scientific marketing to:
  • present your studies — methodology, tables, charts
  • defend your market access, notably during expert reviews
  • produce marketing collateral showcasing your results or products.
Excerpts

Your benefits

What can Direct Epidemio-Statistics bring you?

1

Clarified pathogeneses

Expert help to detect precursor or causal factors that contribute to the emergence, development, or maintenance of adverse events (SAEs).

2

Ambition, results, and performance

To accelerate change and save time, cut direct and ancillary costs, or secure performance with more reliable processes.

3

More simplicity and efficiency

To reduce overall process complexity, improve compliance with rules or standards, gain autonomy and responsiveness, and enhance operational practicality and comfort.

4

A lasting, planned, adaptable partnership

Pre-assess techno-economic feasibility; help you anticipate, plan ahead, and broaden perspective; while staying responsive and available to solve punctual challenges.

5

Advisory, commitment, and trust

A partner who supports you, advises you, respects your approach, and keeps their expertise at your disposal.

The + of Direct Epidemio-Statistics

What makes us specific?

1
First reason: our advisory expertise, which:
  • models your adverse events in a systematic and global way while remaining precise;
  • produces concise, clear, and practical interim and final results;
  • identifies and prioritizes essential improvement levers;
  • integrates these models into your existing systems.
2
Second reason: our French CIR accreditation (R&D tax credit) granted by the Ministry of Higher Education and Research, which:
  • reduces our billed R&D cost by 30% via tax credit;
  • is an indicator of our experience, expertise, and professionalism;
  • covers the period 2022–2027.
3
Third reason: our mindset, characterized by:
  • innovative choices, no taboos, detached from the status quo;
  • punctuality and goal achievement, building reliability and trust;
  • neutrality when surveying possible options;
  • availability and accessibility.